文献速递牙体牙髓病

抗RANKL抗体与唑来膦酸对小鼠根尖周病变发展的影响

Effects of Anti-Receptor Activator of Nuclear Factor Kappa B Ligand Antibody and Zoledronic Acid on Periapical Lesion Development in Mice.
PubMed 文献 · J Endod · 2022-02-15

研究通过小鼠牙髓暴露诱导根尖周炎模型,每周腹腔注射抗RANKL抗体或唑来膦酸至术后第21天,发现两者均剂量依赖性抑制根尖周病变扩大和炎症细胞浸润,但抗RANKL抗体减少破骨细胞数量而唑来膦酸维持破骨细胞数量,提示全身抗骨吸收药可分布于颌骨局部炎症区并阻止根尖周病变发展。

要点

  • 抗RANKL抗体和唑来膦酸均剂量依赖性抑制小鼠根尖周病变扩大。
  • 抗RANKL抗体减少根尖周组织破骨细胞数量,唑来膦酸则维持破骨细胞数量。
  • 两种药物均增加股骨骨量,但根尖周病变组股骨骨密度低于假手术组。

核心结论

  • 全身给予抗骨吸收药物可分布到颌骨局部炎症区域并阻止根尖周病变发展。

研究设计与样本

  • 小鼠牙髓暴露诱导根尖周炎模型,每周腹腔注射抗RANKL抗体或唑来膦酸至术后第21天,行微型CT和组织学分析。

主要发现

  • 抗RANKL抗体和唑来膦酸均剂量依赖性抑制根尖周病变扩大。
  • 两种药物均减少根尖组织炎症细胞浸润并抑制根尖周骨吸收。
  • 抗RANKL抗体减少根尖周组织破骨细胞数量,唑来膦酸抑制骨吸收但维持破骨细胞数量。
  • 两种药物均增加股骨骨量,但根尖周病变组股骨骨密度低于假手术组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Antiresorptive drugs are widely used to treat osteoporosis and other systemic bone diseases, although their efficacy for local bone resorption after localized inflammation has not been fully elucidated. We examined the effects of an anti-receptor activator of nuclear factor kappa B ligand (RANKL) antibody and the bisphosphonate zoledronic acid (ZOL) on periapical lesion (PL) development in mice. METHODS: Dental pulp of lower first molars in mice was removed, with the exposed dental pulp chambers left open to the oral environment to induce apical periodontitis. An anti-RANKL antibody or ZOL was intraperitoneally injected once per week until postoperative day 21, and then micro-computed tomographic imaging and histologic analyses were performed. RESULTS: PL enlargement was inhibited by both the anti-RANKL antibody and ZOL in a dose-dependent manner, and a reduction of inflammatory cell infiltration in apical tissues inhibited periapical bone resorption. The anti-RANKL antibody decreased the number of osteoclasts in periapical tissues, whereas ZOL suppressed periapical bone resorption with osteoclast numbers maintained. Although the administration of each of the antiresorptive drugs increased femoral bone mass, femoral bone mineral density in the PL group was lower compared with the sham-operated group. CONCLUSIONS: These results suggest that an antiresorptive drug administered systemically is distributed to areas of local inflammation in the jaw can prevent PL development.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Ikeda M, Karakawa A, Takizawa H, et al. Effects of Anti-Receptor Activator of Nuclear Factor Kappa B Ligand Antibody and Zoledronic Acid on Periapical Lesion Development in Mice. J Endod. 2022. PMID: 35181456. doi:10.1016/j.joen.2022.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。